iShares Genomics Immunology and Healthcare ETF (IDNA) is a iShares ETF with a 0.47% expense ratio, 59 holdings and $321MM in net assets. Largest sector: Healthcare (100%).
Fee
0.47%
expense ratio
Net assets
$321MM
Launched
Jun 11, 2019
Holdings
59
as of Oct 16, 2026
Top 10 weight
49.2%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 0.30% · TTM 0.66%
as of Sep 30, 2026
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
IDNA's holdings are as of Oct 16, 2026.
Healthcare
100.0%
1
MRNA
MODERNA
13.30%
2
TWST
TWIST BIOSCIENCE
5.55%
3
IOVA
Iovance Biotherapeutics
4.80%
4
GMAB
Genmab A/S
4.42%
5
4502
Takeda Pharmaceutical Ltd
3.70%
6
REGN
REGENERON PHARMACEUTICALS
3.60%
7
MRK
MERCK
3.50%
8
BAYN
BAYER AG
3.47%
9
RVMD
Revolution Medicines
3.45%
10
EXEL
Exelixis
3.41%
11
CAI
Caris Life Sciences
3.40%
12
VRTX
VERTEX PHARMACEUTICALS
3.24%
13
ROP
Roche Holding AG
3.24%
14
INCY
INCYTE
3.19%
15
IBRX
ImmunityBio
3.14%
16
BNTX
Biontech Se
2.88%
17
GSK
GLAXOSMITHKLINE CAPITAL
2.78%
18
IPN
IPSEN SA
2.66%
19
SAN
SANOFI SA
2.60%
20
ABCL
ABCELLERA BIOLOGICS
2.51%
21
IDYA
Ideaya Biosciences
2.48%
22
RCUS
Arcus Biosciences
1.68%
23
NVAX
Novavax
1.60%
24
4528
Ono Pharmaceutical Ltd
1.55%
25
CRSP
CRISPR THERAPEUTICS AG
1.28%
1–25 of 59
Funds listed by how much of their largest holdings they share with IDNA — not a ranking.
Data from iShares; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.